CD4 and inflammatory bowel disease: The observation that CIC is often heavily infiltrated by CD8 + T cell and CD4 + T cells raises the question whether T cell–selective agents including tacrolimus, cyclosporine, or ustekinumab that are used in aGVHD and IBD may be beneficial in CIC treatment [36–38].